Erschienen in:
29.05.2020 | EDITORIAL
Thanks to CLD for Small Favors: Reduced CVD Risk in Patients Awaiting Liver Transplantation
verfasst von:
Hersh Shroff, Mary E. Rinella
Erschienen in:
Digestive Diseases and Sciences
|
Ausgabe 1/2021
Einloggen, um Zugang zu erhalten
Excerpt
Over the past two decades, there has been a shift in the prevailing etiologies of chronic liver disease (CLD), both in the USA and worldwide [
1]. Since the advent of direct acting antivirals (DAAs), the burden of hepatitis C virus (HCV)-related CLD has steadily decreased, whereas that of nonalcoholic fatty liver disease (NAFLD) has increased, attributable largely to higher global rates of obesity and diabetes. As a result, nonalcoholic steatohepatitis (NASH) and alcoholic liver disease (ALD) have now surpassed HCV as the leading indications for liver transplant (LT) evaluation in the USA [
2]. …